| (CAD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 144.21M | — |
| Operating expense | — | — |
| Net income | -3.36M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, GUD.TO returned +48.4% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +58.2% |
| 1 year | +48.4% |
| 5 years | +78.2% |
| 10 years | +9.2% |
| All-time high | $10.74 (Dec 2016) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in GUD.TO would be worth today ›No. Knight Therapeutics Inc. has not paid a dividend in the past 12 months.
Knight Therapeutics Inc. is part of the Healthcare sector.
Knight Therapeutics Inc. has a market cap of 940.08M CAD, based on the latest quote.
Knight Therapeutics Inc. is expected to report earnings around Nov 5, 2026. That date is an estimate and has not been confirmed by the company.
